AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion
This collaboration highlights the growing reliance on AI in pharma, potentially accelerating drug discovery and reshaping industry dynamics. The post AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion appeared first on Crypto Briefing.
AI summary
AstraZeneca signed an AI drug discovery deal with insitro worth up to $1.86 billion. The collaboration underscores pharma's growing reliance on AI to accelerate drug development. There is no direct crypto market impact, though it may support long-term AI narrative sentiment.
